Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
The use of omalizumab in allergen immunotherapy
J. A. Dantzer
,
R. A. Wood
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
49
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The use of omalizumab in allergen immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Omalizumab
100%
Immunologic Desensitization
93%
Venoms
27%
Immunotherapy
27%
Asthma
17%
Randomized Controlled Trials
10%
Chronic Urticaria
10%
Arachis
10%
anti-IgE antibodies
10%
Seasonal Allergic Rhinitis
9%
Food Hypersensitivity
9%
Allergic Rhinitis
8%
Ovum
7%
Allergens
7%
Duration of Therapy
7%
Milk
7%
Publications
6%
Therapeutics
6%
Hypersensitivity
6%
PubMed
6%
Food
5%
Placebos
5%